Stockscreener 앱 받기
1.075
2.71%
-0.03
전일 마감가:
$1.105
열려 있는:
$1.05
하루 거래량:
223.41K
Relative Volume:
0.08
시가총액:
$73.16M
수익:
-
순이익/손실:
$-46.12M
주가수익비율:
-1.2439
EPS:
-0.8642
순현금흐름:
$-41.02M
1주 성능:
-14.68%
1개월 성능:
-13.31%
6개월 성능:
+26.62%
1년 성능:
-56.30%
1일 변동 폭
$1.05
$1.12
1주일 범위
$0.9201
$1.2472
52주 변동 폭
$0.7113
$2.815
Inflarx N V Stock (IFRX) Company Profile
IFRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IFRX
Inflarx N V
|
1.0799 | 74.52M | 0 | -46.12M | -41.02M | -0.8642 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.78 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
720.17 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.64 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.99 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inflarx N V Stock (IFRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-03 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-09-02 | 재개 | H.C. Wainwright | Buy |
| 2025-05-29 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-05 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-02-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-10-28 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-03-11 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-11-06 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-10-08 | 개시 | H.C. Wainwright | Buy |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-04-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2019-06-05 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-06-05 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-05 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2019-06-05 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-06-05 | 다운그레이드 | SunTrust | Buy → Hold |
| 2019-01-29 | 개시 | Robert W. Baird | Outperform |
| 2018-12-10 | 개시 | Credit Suisse | Outperform |
| 2018-07-13 | 개시 | BMO Capital Markets | Outperform |
| 2018-06-28 | 개시 | Raymond James | Outperform |
| 2018-06-28 | 개시 | SunTrust | Buy |
| 2018-02-08 | 개시 | B. Riley FBR, Inc. | Buy |
모두보기
Inflarx N V 주식(IFRX)의 최신 뉴스
InflaRx (NASDAQ:IFRX) Downgraded to "Hold" Rating by Leerink Partnrs - MarketBeat
How InflaRx N.V. (IF0) stock moves in volatile trading sessions2025 Technical Overview & Reliable Volume Spike Alerts - Newser
InflaRx (NASDAQ:IFRX) Stock Rating Lowered by Leerink Partnrs - Defense World
Will InflaRx N.V. stock outperform Nasdaq indexJuly 2025 Update & Community Supported Trade Ideas - Newser
Is InflaRx N.V. (IF0) stock testing key supportWeekly Market Report & Risk Controlled Swing Alerts - Newser
InflaRx (IFRX) Downgraded by Leerink Partners with Lowered Price Target | IFRX Stock News - GuruFocus
Leerink Partners downgrades Inflarx stock rating to Market Perform on financing concerns - Investing.com Nigeria
Leerink Partners Downgrades InflaRx to Market Perform From Outperform, Adjusts PT to $2 From $5 - marketscreener.com
InflaRx N.V. (IFRX) 5.6% in After-hours: What’s Driving the Move? - Stocks Telegraph
Will InflaRx N.V. (IF0) stock deliver compounding returns2025 Investor Takeaways & Capital Efficiency Focused Strategies - Newser
Is InflaRx N.V. (IF0) stock supported by strong fundamentalsStop Loss & Verified Short-Term Trading Plans - Newser
What margin trends mean for InflaRx N.V. stock2025 Market Outlook & AI Forecasted Entry/Exit Points - Newser
Inflarx flexes; HS, CSU continue to percolate - BioWorld MedTech
Ready to Jump After Recent Trade: InflaRx N.V (IFRX) - Setenews
Cash per share of InflaRx N.V. – BER:IF0 - TradingView
InflaRx N.V. (NASDAQ:IFRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Can InflaRx N.V. (IF0) stock surprise with quarterly results2025 Trade Ideas & Weekly Watchlist for Hot Stocks - newser.com
Will InflaRx N.V. stock deliver strong dividend growthGold Moves & AI Enhanced Trading Signals - newser.com
Is InflaRx N.V. stock attractive for income investorsEarnings Risk Report & Stepwise Trade Execution Plans - newser.com
Can InflaRx N.V. stock sustain market leadershipWeekly Trend Recap & AI Driven Price Predictions - newser.com
InflaRx N.V. stock prediction for this weekMarket Rally & AI Driven Price Predictions - newser.com
Is InflaRx N.V. (IF0) stock cheap vs fundamentalsJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
InflaRx Stock: Gohibic Flops, INF904 Underwhelms, Cash Burn Accelerates (NASDAQ:IFRX) - Seeking Alpha
Can InflaRx N.V. recover in the next quarter2025 Stock Rankings & Technical Pattern Based Signals - newser.com
Will InflaRx N.V. (IF0) stock maintain strong growthMarket Growth Review & Low Risk High Reward Ideas - newser.com
Why InflaRx N.V. stock is considered a top pickMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com
Volatility clustering patterns for InflaRx N.V.Entry Point & Risk Managed Investment Signals - newser.com
Inflarx N V (IFRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.40%
1.11%
자본화:
|
볼륨(24시간):